Patents by Inventor Maciej LESNIAK

Maciej LESNIAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20210060101
    Abstract: In some embodiments, methods of killing tumor cells are provided. The methods may include contacting the tumor cell with a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective element and/or a capsid protein that binds a tumor-specific cell surface molecule. In another embodiment, methods of treating cancer are provided. The methods may include administering a therapeutically effective amount of a pharmaceutical composition to a subject, wherein the pharmaceutical composition includes a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective promoter element and/or a capsid protein that binds a tumor-specific cell surface molecule.
    Type: Application
    Filed: July 13, 2020
    Publication date: March 4, 2021
    Applicants: CITY OF HOPE, UNIVERSITY OF CHICAGO, UNIVERSITY OF ALABAMA AT BIRMINGHAM
    Inventors: Karen S. ABOODY, Alexander J. ANNALA, David CURIEL, Maciej LESNIAK
  • Tropic cell based virotherapy for the treatment of cancer
    Patent number: 10709745
    Abstract: In some embodiments, methods of killing tumor cells are provided. The methods may include contacting the tumor cell with a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective element and/or a capsid protein that binds a tumor-specific cell surface molecule. In another embodiment, methods of treating cancer are provided. The methods may include administering a therapeutically effective amount of a pharmaceutical composition to a subject, wherein the pharmaceutical composition includes a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective promoter element and/or a capsid protein that binds a tumor-specific cell surface molecule.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: July 14, 2020
    Assignees: CITY OF HOPE, UNIVERSITY OF ALABAMA AT BIRMINGHAM, UNIVERSITY OF CHICAGO
    Inventors: Karen S. Aboody, Alexander J. Annala, David Curiel, Maciej Lesniak
  • TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20190275093
    Abstract: In some embodiments, methods of killing tumor cells are provided. The methods may include contacting the tumor cell with a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective element and/or a capsid protein that binds a tumor-specific cell surface molecule. In another embodiment, methods of treating cancer are provided. The methods may include administering a therapeutically effective amount of a pharmaceutical composition to a subject, wherein the pharmaceutical composition includes a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective promoter element and/or a capsid protein that binds a tumor-specific cell surface molecule.
    Type: Application
    Filed: March 21, 2019
    Publication date: September 12, 2019
    Inventors: Karen S. ABOODY, Alexander J. ANNALA, David CURIEL, Maciej LESNIAK
  • Tropic cell based virotherapy for the treatment of cancer
    Patent number: 10238699
    Abstract: In some embodiments, methods of killing tumor cells are provided. The methods may include contacting the tumor cell with a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective element and/or a capsid protein that binds a tumor-specific cell surface molecule. In another embodiment, methods of treating cancer are provided. The methods may include administering a therapeutically effective amount of a pharmaceutical composition to a subject, wherein the pharmaceutical composition includes a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective promoter element and/or a capsid protein that binds a tumor-specific cell surface molecule.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: March 26, 2019
    Assignees: CITY OF HOPE, UNIVERSITY OF CHICAGO, UNIVERSITY OF ALABAMA AT BIRMINGHAM
    Inventors: Karen S. Aboody, Alexander J. Annala, David Curiel, Maciej Lesniak
  • TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER
    Publication number: 20160317591
    Abstract: In some embodiments, methods of killing tumor cells are provided. The methods may include contacting the tumor cell with a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective element and/or a capsid protein that binds a tumor-specific cell surface molecule. In another embodiment, methods of treating cancer are provided. The methods may include administering a therapeutically effective amount of a pharmaceutical composition to a subject, wherein the pharmaceutical composition includes a tropic cell that carries a modified oncolytic virus, wherein the virus comprises a tumor selective promoter element and/or a capsid protein that binds a tumor-specific cell surface molecule.
    Type: Application
    Filed: September 11, 2015
    Publication date: November 3, 2016
    Inventors: Karen S. ABOODY, Alexander J. ANNALA, David CURIEL, Maciej LESNIAK